If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBP Regulatory News (BP.)

Share Price Information for BP (BP.)

Share Price is delayed by 15 minutes
Get Live Data
464.40    8.80 (1.93%)
Bid:
464.10
Ask:
464.25
Spread: 0.15 (0.032%)
Market Cap: £71.75b
BP. Live PriceLast checked at - London Stock Exchange

Intraday BP Share Chart

Director/PDMR Shareholding

1 May 2025 16:40

RNS Number : 1301H
BP PLC
01 May 2025
Β 

BP p.l.c.

Notification of transactions of persons discharging managerial responsibility or connected persons

EDIP performance shares 2025-2027 award

BP p.l.c. (the "Company") announces that, on 30 April 2025, conditional performance share awards (the "Awards") were made under the bp Executive Directors' Incentive Plan (the "Plan"). The Awards were made in accordance with the rules of the Plan and the 2023 directors' remuneration policy (the "Policy") and as provided for in the 2024 directors' remuneration report (the "Report"), which were approved by shareholders on 27 April 2023 and 17 April 2025 respectively.

Level of award

The Remuneration Committee (the "Committee") has made these Awards at 500% of base salary for the chief executive officer and 450% for the chief financial officer, in line with the Policy. In calculating the number of bp shares over which these Awards have been made, the Committee has applied the average price of bp shares over the 90 calendar days up to and including the annual general meeting that was held on 17 April 2025 (Β£4.21).

The Committee retains absolute discretion to adjust the formulaic outcome at the time of vesting of the Awards should it not reflect the shareholder experience over the performance period or be otherwise inconsistent with the size of the Award.

Performance conditions

As set out in the Policy and Report, Awards will vest subject to performance against a combination of the following financial and strategic measures:

Β· Relative total shareholder return (25%) assessed against a benchmarking group, comprising Chevron, Eni, Equinor, ExxonMobil, Repsol, Shell and TotalEnergies;

Β· Return on average capital employed (20%);

Β· Adjusted free cash flow compound annual growth rate per share (20%);

Β· Cumulative reduction percentage in operated carbon emissions (15%); and

Β· Strategic progress (20%), where consideration may be given to the following measures and a holistic review by the Committee of progress against strategy set out in the Capital Markets Update in February 2025:

oΒ  Divestments

oΒ  Net debt

oΒ  Structural cost reduction.

Number of shares subject to award

Name

Award

Murray Auchincloss

1,790,973 ordinary shares

Kate Thomson

923,515 ordinary shares

Β 

These awards will vest in three years and in proportion to the outcomes measured through the performance scorecard, with a holding period that requires the shares to be retained for a further three years. The executive directors will be entitled to the value of reinvested dividends on those ordinary shares which vest.

Β 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Murray Auchincloss

2

Reason for the notification

a)

Position/status

Chief executive officer / Director

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

BP p.l.c.

b)

LEI

213800LH1BZH3DI6G760

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of $0.25

GB0007980591

b)

Nature of the transaction

1,790,973 performance share units (in the form of ordinary shares) awarded under the bp Executive Directors' Incentive Plan.

c)

Price(s) and volume(s)

Β 

Price(s)

Volume(s)

Nil consideration

1,790,973

d)

Aggregated information

- Volume

Β 

- Price

Β 

- Total

Β 

1,790,973

Β 

Nil consideration. Market value Β£4.21

Β 

Nil consideration. Market value Β£7,539,996.33

e)

Date of the transaction

30 April 2025

f)

Place of the transaction

Outside a trading venue

Β 

Β 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Kate Thomson

2

Reason for the notification

a)

Position/status

Chief financial officer / Director

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

BP p.l.c.

b)

LEI

213800LH1BZH3DI6G760

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of $0.25

GB0007980591

b)

Nature of the transaction

923,515 performance share units (in the form of ordinary shares) awarded under the bp Executive Directors' Incentive Plan.

c)

Price(s) and volume(s)

Β 

Price(s)

Volume(s)

Nil consideration

923,515

d)

Aggregated information

- Volume

Β 

- Price

Β 

- Total

Β 

923,515

Β 

Nil consideration. Market value Β£4.21

Β 

Nil consideration. Market value Β£3,887,998.15

e)

Date of the transaction

30 April 2025

f)

Place of the transaction

Outside a trading venue

Β 

This notice is given in fulfilment of the obligation under Article 19 of the Market Abuse Regulation.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHPKDBNPBKDFPK
Date   Source Headline
30th Mar 20235:41 pmRNSTransaction in Own Shares
29th Mar 20235:21 pmRNSTransaction in Own Shares
28th Mar 20235:36 pmRNSTransaction in Own Shares
27th Mar 20235:46 pmRNSTransaction in Own Shares
24th Mar 20235:02 pmRNSTransaction in Own Shares
23rd Mar 20235:21 pmRNSTransaction in Own Shares
23rd Mar 202311:00 amRNSDirector/PDMR Shareholding
22nd Mar 20234:57 pmRNSTransaction in Own Shares
21st Mar 20234:59 pmRNSTransaction in Own Shares
20th Mar 20235:13 pmRNSTransaction in Own Shares
17th Mar 20235:12 pmRNSTransaction in Own Shares
16th Mar 20235:37 pmRNSTransaction in Own Shares
15th Mar 20235:24 pmRNSTransaction in Own Shares
15th Mar 20237:00 amRNSTransaction in Own Shares
14th Mar 202310:03 amRNSPayment of dividends in sterling
13th Mar 20236:00 pmRNSTransaction in Own Shares
13th Mar 20231:59 pmRNSDirector/PDMR Shareholding
13th Mar 20237:00 amRNSTransaction in Own Shares
10th Mar 20239:18 amRNSAnnual Report and Form 20-F 2022 & Notice of AGM
9th Mar 20235:33 pmRNSTransaction in Own Shares
9th Mar 20237:00 amRNSTransaction in Own Shares
7th Mar 20236:03 pmRNSTransaction in Own Shares
6th Mar 20236:17 pmRNSTransaction in Own Shares
6th Mar 20237:00 amRNSTransaction in Own Shares
3rd Mar 202312:00 pmRNSPreliminary announcement of publication date
2nd Mar 20235:58 pmRNSTransaction in Own Shares
2nd Mar 20237:00 amRNSTransaction in Own Shares
1st Mar 20233:31 pmRNSTotal Voting Rights
28th Feb 20235:48 pmRNSTransaction in Own Shares
27th Feb 20235:40 pmRNSTransaction in Own Shares
24th Feb 20235:23 pmRNSTransaction in Own Shares
23rd Feb 20235:50 pmRNSTotal Voting Rights
23rd Feb 20235:45 pmRNSTransaction in Own Shares (Replacement)
23rd Feb 20235:44 pmRNSTransaction in Own Shares (Replacement)
23rd Feb 20235:22 pmRNSTransaction in Own Shares
22nd Feb 20235:06 pmRNSTransaction in Own Shares
21st Feb 20235:09 pmRNSTransaction in Own Shares
20th Feb 20235:14 pmRNSTransaction in Own Shares
20th Feb 20235:11 pmRNSDirector Declaration
17th Feb 20235:22 pmRNSTransaction in Own Shares
17th Feb 20239:27 amRNSDirector/PDMR Shareholding
16th Feb 20235:29 pmRNSTransaction in Own Shares
16th Feb 20237:00 amRNSTransaction in Own Shares
15th Feb 20237:00 amRNSTransaction in Own Shares
13th Feb 20236:14 pmRNSHolding(s) in Company
13th Feb 20235:47 pmRNSTransaction in Own Shares
13th Feb 20235:39 pmRNSTotal Voting Rights
10th Feb 20234:58 pmRNSTotal Voting Rights
10th Feb 20234:22 pmRNSDirector/PDMR Shareholding
7th Feb 20235:40 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.